Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
At Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC), our researchers are on the forefront of studying and developing new and effective treatments for rectal cancer, including clinical trials.
Patients come to us from around the world to be seen by our highly specialized team, made up of some of the best practitioners in every medical discipline. Our team is advancing national standards of care through breakthrough research and innovative methods of preventing, diagnosing, and treating rectal cancer.
In addition to researchers, our team of specialists includes medical oncologists, surgeons, and radiation oncologists who focus exclusively on gastrointestinal cancers, including colon cancer.
See the complete list of our gastrointestinal cancer specialists.
Appointments and Second Opinions